©2024 Stanford Medicine
Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation
Not Recruiting
Trial ID: NCT01182155
Purpose
Patients treated with radiation therapy for lung tumors can experience inflammation after
treatment. This study hopes to evaluate the use of breath analysis to evaluate changes in the
composition of exhaled breath in patients undergoing radiotherapy. If changes can be
detected, this may ultimately serve as biomarkers for identifying patients at highest risk
for radiation-induced lung injury (radiation pneumonitis).
Official Title
Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation: A Feasibility Study
Stanford Investigator(s)
Maximilian Diehn, MD, PhD
Jack, Lulu, and Sam Willson Professor and Professor of Radiation Oncology (Radiation Therapy)
Billy W Loo, Jr, MD PhD FASTRO FACR
Professor of Radiation Oncology (Radiation Therapy)
Eligibility
Inclusion Criteria:
- Diagnosis of any type of lung tumor
- Medical recommendation (independent of the study) that the patient undergo thoracic
radiation therapy. Radiation therapy may be either fractionated or hypofractionated
(i.e. radiosurgery)
- Age >= 18 years old
- Any gender and any ethnic background will be recruited
- Capable of giving written informed consent
Exclusion Criteria:
- Inability of giving written informed consent
- Pregnancy or breast-feeding
Intervention(s):
procedure: Exhaled Breath Sampling
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
ccto-office@stanford.edu
650-498-7061